The National Academies
Institute of Medicine
Committee on Review of NIP’s Research Procedures and Data Sharing Program
Meeting Two
AGENDA
Speakers and Times Subject to Change
Thursday, October 21, 2004
9:00 a.m. – 5:30 p.m.
|
Meeting Location: |
Keck Center of the National Academies Room 100 500 Fifth Street, NW Washington, DC 20001 |
|
8:30–9:00 a.m. |
Registration and Coffee |
|
9:00–9:15 a.m. |
Welcome, Introductions, and Opening Statement |
|
|
John Bailar, MD, PhD Committee Chair |
|
9:15–9:35 a.m. |
Charge to the Committee—Second Component of Charge |
|
|
Roger Bernier, PhD, MPH Senior Advisor for Scientific Strategy and Innovation National Immunization Program Centers for Disease Control and Prevention |
|
9:35–9:50 a.m. |
Questions from the Committee |
|
9:50–10:10 a.m. |
A Peer-Reviewed Journal’s Perspective on the Release of Preliminary Findings |
|
|
Harold Sox, MD Editor Annals of Internal Medicine American College of Physicians of Internal Medicine |
|
10:10–10:25 a.m. |
Questions from the Committee |
|
10:25–10:40 a.m. |
Break |
|
10:40–11:00 a.m. |
When to Release Preliminary Findings: Ethical Considerations |
|
|
Charles Weijer, MD, PhD, FRCPC CIHR Investigator Associate Professor of Bioethics, Medicine, and Surgery Adjunct Professor of Philosophy Department of Bioethics Dalhousie Medical School |
|
11:00–11:15 a.m. |
Questions from the Committee |
|
11:15–11:35 a.m. |
Communicating Health Risks Identified Through Preliminary Analyses |
|
|
Katherine McComas, PhD Assistant Professor Department of Communication Cornell University |
|
11:35–11:50 a.m. |
Questions from the Committee |
|
11:50–12:10 p.m. |
When to Release Preliminary Findings: Post-Market Surveillance of Medical Devices |
|
|
Susan Gardner, PhD Director, Office of Surveillance Biometrics Center for Devices and Radiological Health Food and Drug Administration |
|
12:10–12:25 p.m. |
Questions from the Committee |
|
12:25–1:30 p.m. |
Lunch (Cafeteria on 3rd Floor; List of nearby restaurants in folder) |
|
1:30–2:00 p.m. |
VSD Studies that Utilized Iterative Analyses |
|
|
Frank DeStefano, MD, MPH Medical Epidemiologist National Immunization Program Centers for Disease Control and Prevention |
|
2:00–2:15 p.m. |
Questions from the Committee |
|
2:15–2:35 p.m. |
Statistical Methods and Issues Relevant to Iterative Analyses |
|
|
David DeMets, PhD Professor and Chair Department of Biostatistics and Medical Informatics University of Wisconsin-Madison |
|
2:35–2:50 p.m. |
Questions from the Committee |
|
2:50–3:10 p.m. |
Use of Preliminary Findings for Policy Decisions: The Rotavirus Vaccine Experience |
|
|
Melinda Wharton, MD, MPH Acting Deputy Director National Immunization Program Centers for Disease Control and Prevention |
|
3:10–3:25 p.m. |
Questions from the Committee |
|
3:25–3:40 p.m. |
Break |
|
3:40–4:00 p.m. |
Advocacy Group Perspective on Criteria for Releasing Preliminary Findings |
|
|
Sallie Bernard Executive Director and Co-Founder SafeMinds |
|
4:00–4:15 p.m. |
Questions from the Committee |
|
4:15–4:35 p.m. |
Pediatricians’ Perspective on Preliminary Findings as Evidence for Decision-Making |
|
|
Julia McMillan, MD Professor of Pediatrics Vice Chair for Pediatric Education Johns Hopkins University School of Medicine |
|
4:35–4:50 p.m. |
Questions from the Committee |
|
4:50–5:20 p.m. |
Public Comment (A sign-up sheet will be available at the registration table) |
|
5:20–5:30 p.m. |
Closing Remarks |
|
|
John Bailar, MD, PhD Committee Chair |